Canada markets closed

Stryker Corporation (SYK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
283.14+0.66 (+0.23%)
At close: 04:03PM EST
283.70 +0.56 (+0.20%)
After hours: 07:33PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close282.48
Bid0.00 x 800
Ask0.00 x 1200
Day's Range280.52 - 284.00
52 Week Range188.84 - 284.00
Avg. Volume1,397,108
Market Cap107.149B
Beta (5Y Monthly)0.95
PE Ratio (TTM)45.89
Earnings DateN/A
Forward Dividend & Yield3.00 (1.06%)
Ex-Dividend DateDec 29, 2022
1y Target EstN/A
  • GlobeNewswire

    Stryker reports 2022 operating results and 2023 outlook

    Kalamazoo, Michigan , Jan. 31, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022: Fourth Quarter Results Reported net sales increased 10.7% to $5.2 billionOrganic net sales increased 13.2%Reported operating income margin of 15.6%Adjusted operating income margin(1) contracted 70 bps to 26.6%Reported EPS decreased 15.0% to $1.47Adjusted EPS(1) increased 10.7% to $3.00 Fourth Quarter Net Sales Growth Overview Reported Foreign Currenc

  • GlobeNewswire

    Stryker to host conference call on January 31, 2023

    Kalamazoo, Michigan, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update. Final operating results for the quarter will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker’s Q4 and Full Year 2022 Earnings Call. After re

  • Business Wire

    Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process

    KALAMAZOO, Mich., December 13, 2022--Stryker (NYSE:SYK) today announced the launch of Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new system uses Citregen™, an award-winning bioresorbable material designed to mimic the chemistry and structure of native bone.1